Maria Paximadis to Genotype
This is a "connection" page, showing publications Maria Paximadis has written about Genotype.
Connection Strength
0,400
-
Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population. Hum Immunol. 2012 Jan; 73(1):80-92.
Score: 0,085
-
Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub-Saharan African Populations. Clin Pharmacol Ther. 2024 03; 115(3):576-594.
Score: 0,049
-
Characterization of CYP2D6 Pharmacogenetic Variation in Sub-Saharan African Populations. Clin Pharmacol Ther. 2023 03; 113(3):643-659.
Score: 0,046
-
An HIV Vaccine Protective Allele in FCGR2C Associates With Increased Odds of Perinatal HIV Acquisition. Front Immunol. 2021; 12:760571.
Score: 0,043
-
The impact of bone marrow stromal antigen-2 (BST2) gene variants on HIV-1 control in black South African individuals. Infect Genet Evol. 2020 06; 80:104216.
Score: 0,038
-
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation. Nat Commun. 2019 01 24; 10(1):412.
Score: 0,035
-
Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations. Hum Immunol. 2017 Jul - Aug; 78(7-8):503-509.
Score: 0,031
-
Human leukocyte antigen class I (A, B and C) allele and haplotype variation in a South African Indian population. Hum Immunol. 2017 Jul - Aug; 78(7-8):468-470.
Score: 0,031
-
Killer-cell immunoglobulin-like receptor genotyping and HLA killer-cell immunoglobulin-like receptor-ligand identification by real-time polymerase chain reaction. Tissue Antigens. 2011 Sep; 78(3):185-94.
Score: 0,021
-
Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype. J Acquir Immune Defic Syndr. 2011 Jul 01; 57(3):181-9.
Score: 0,021